Upgrade to SI Premium - Free Trial

Viridian Therapeutic (VRDN) PT Lowered to $30 at RBC Capital

April 7, 2026 5:44 AM
RBC Capital analyst Lisa Walter lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $30.00 (from $42.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change